Pfizer intends to provide additional commentary and all components of its updated full-year 2023 guidance in its Third-Quarter 2023 Performance Report to be issued on Tuesday, October 31, 2023. Pfizer COVID-19 Treatment Transition Albert Bourla announces an important agreement with t...